EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases

Luisa V. Licker, Tim Schikowski, Juliane Schiller, Franziska Püschner, Volker E. Amelung, Dirk Meyer-Olson, Torsten Witte, Kirsten Hoeper, Jan Zeidler

The European Journal of Health Economics · 21.11.2026

DOI: 10.1007/s10198-026-02015-1 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The European Journal of Health Economics, online erschienen am 21.11.2026. Verfasst von Luisa V. Licker und 8 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gottfried Wilhelm Leibniz Universität Hannover.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the increasing shortage of medical specialists in Germany, delegating selected physician tasks to nurses has been proposed to maintain care quality for patients with chronic inflammatory diseases (CID). This study evaluated the health economic impact of a nurse-led care (NLC) model, in which nurses conducted structured, delegated consultations, compared with standard specialist care, within the Deliver-Care randomized controlled trial. This trial, conducted between 2020 and 2023 at 56 specialist outpatient practices and hospital clinics, randomized 602 patients with rheumatological, gastroenterological, or dermatological CID to the intervention group (IG, n = 295) or control group (CG, n = 307). Healthcare costs (FIMA questionnaire) were assessed at baseline and 12 months, and EQ-5D-based utility values at baseline, 6 and 12 months. Analyses followed the intention-to-treat principle, with missing data handled using multiple imputation. Group differences in costs were assessed using generalized estimating equations, and cost-effectiveness was evaluated using bootstrapping (5,000 replications) and cost-effectiveness acceptability curves. Mean total costs at 12 months were €12,061 (IG) versus €13,601 (CG), a non-significant difference ( p = 0.286), with no significant group-by-time interaction. QALY gains were comparable between groups (IG: 0.80; CG: 0.78). The intervention was dominant in 87.2% of bootstrap replications, with a 94% probability of cost-effectiveness at a willingness-to-pay threshold of €50,000 per QALY. While no significant reduction in healthcare costs or improvement in quality of life were observed, the NLC model showed a high probability of cost-effectiveness, suggesting it may serve as a cost-neutral to potentially cost-saving alternative to standard care.

Förderung

  • Gottfried Wilhelm Leibniz Universität Hannover

Zitieren

APA

Licker, L. V., Schikowski, T., Schiller, J., Püschner, F., Amelung, V. E., Meyer-Olson, D., Witte, T., Hoeper, K., & Zeidler, J. (2026). Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases. The European Journal of Health Economics. https://doi.org/10.1007/s10198-026-02015-1

Vancouver

Licker LV, Schikowski T, Schiller J, Püschner F, Amelung VE, Meyer-Olson D, et al. Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases. The European Journal of Health Economics. 2026. doi:10.1007/s10198-026-02015-1

BibTeX
@article{Licker2026,
  author = {Licker, Luisa V. and Schikowski, Tim and Schiller, Juliane and Püschner, Franziska and Amelung, Volker E. and Meyer-Olson, Dirk and Witte, Torsten and Hoeper, Kirsten and Zeidler, Jan},
  title = {Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases},
  journal = {The European Journal of Health Economics},
  year = {2026},
  doi = {10.1007/s10198-026-02015-1}
}
Kostenlos starten →